Brad Morganstern, MD (@bradmorganstern) 's Twitter Profile
Brad Morganstern, MD

@bradmorganstern

@NYULangoneLI Medical Director, IBD Program - Long Island Tweets are my own. RT ≠ endorsement

ID: 120481509

linkhttps://nyulangone.org/doctors/1750540449/bradley-m-morganstern calendar_today06-03-2010 15:23:13

1,1K Tweet

1,1K Followers

930 Following

Simon Hong (@simonhongmd) 's Twitter Profile Photo

Kicking off NYU Langone Health Big Gut IBD 2024! Gil Y. Melmed, MD, MS reviews 1st-line 💉💊 for UC. Some highlights: ▶️ RCTs finally assessing proctitis and urgency ▶️ small molecules continue to show rapid onset of action ▶️ NO matter what you choose from the “buffet” - monitor and T2T!

Kicking off <a href="/nyulangone/">NYU Langone Health</a> Big Gut IBD 2024! <a href="/GilMelmedMD/">Gil Y. Melmed, MD, MS</a> reviews 1st-line 💉💊 for UC. Some highlights:
▶️ RCTs finally assessing proctitis and urgency
▶️ small molecules continue to show rapid onset of action
▶️ NO matter what you choose from
the “buffet” - monitor and T2T!
Sophie Balzora, MD, FACG (@sophiebalzoramd) 's Twitter Profile Photo

Dr. Lisa Malter presents the newer paradigm in the treatment pyramid for mod/severe #Crohns. Importantly, steroids are no longer included in the pyramid given its ADEs and use only in the short term. Undertreatment is also considered an ADE of sorts. Impt shift in mindset! #IBD

Dr. Lisa Malter presents the newer paradigm in the treatment pyramid for mod/severe #Crohns. Importantly, steroids are no longer included in the pyramid given its ADEs and use only in the short term. Undertreatment is also considered an ADE of sorts. Impt shift in mindset! #IBD
Adam Faye MD MS (@adamfayemd) 's Twitter Profile Photo

Amazing talk Sophie Balzora, MD, FACG on Social Determinants of Health in #IBD 🚨impact —> higher food insecurity, lower social support, increased hospitalization, lower used of advanced therapies- inclusion in RCTs impt to move from equality —> equity ABGH David Hudesman

Amazing talk <a href="/SophieBalzoraMD/">Sophie Balzora, MD, FACG</a> on Social Determinants of Health in #IBD
🚨impact —&gt; higher food insecurity, lower social support, increased hospitalization, lower used of advanced therapies- inclusion in RCTs
impt to move from equality —&gt; equity <a href="/blackingastro/">ABGH</a> <a href="/DavidHudesmanMD/">David Hudesman</a>
Mark B. Pochapin, MD (@markpochapin) 's Twitter Profile Photo

Incredible line while giving a presentation during the earthquake: “This is how impactful IUS (Intestinal Ultrasound) is in IBD care … It shakes the earth”. #BigGutIBD2024

Simon Hong (@simonhongmd) 's Twitter Profile Photo

Keynote lecture by Millie Long on the current status of precision 💊 in IBD NYU Langone Health #biggutibd Some 🔑: 1️⃣ Profile UK: 🚫 utility of PredictSURE, but DID show benefit of early combo 2️⃣ Can use HLA-DQ A1*05, TPMT & NUDT15 to guide TNFa/IMM 3️⃣ TL1A’s (+ companion dx) on the way!

Keynote lecture by <a href="/MLongMD/">Millie Long</a> on the current status of precision 💊 in IBD <a href="/nyulangone/">NYU Langone Health</a> #biggutibd

Some 🔑:
1️⃣ Profile UK: 🚫 utility of PredictSURE, but DID show benefit of early combo
2️⃣ Can use HLA-DQ A1*05, TPMT &amp; NUDT15 to guide TNFa/IMM
3️⃣ TL1A’s (+ companion dx) on the way!
Simon Hong (@simonhongmd) 's Twitter Profile Photo

Updates on acute severe UC by Jordan Axelrad, MD, MPH at NYU Langone Health #biggutIBD! CDI+ is a poor prognostic factor, inpatient IFX 5 mg/kg 🟰 10mg/kg, and JAKi are now an effective option (but can still use cyclo☝️)

Updates on acute severe UC by <a href="/DrJordanAxelrad/">Jordan Axelrad, MD, MPH</a> at <a href="/nyulangone/">NYU Langone Health</a> #biggutIBD! CDI+ is a poor prognostic factor, inpatient IFX 5 mg/kg 🟰 10mg/kg, and JAKi are now an effective option (but can still use cyclo☝️)
Sherman Prize (@shermanprize) 's Twitter Profile Photo

Congratulations 2024 Emerging Leader Prize Recipient Jordan Axelrad, MD, MPH, NYU Langone Health NYU Grossman School of Medicine. Dr. Axelrad's own experience with Crohn’s disease drives his commitment to improving patient outcomes. Learn more about his work at ShermanPrize.org

Congratulations 2024 Emerging Leader Prize Recipient <a href="/DrJordanAxelrad/">Jordan Axelrad, MD, MPH</a>, <a href="/nyulangone/">NYU Langone Health</a> <a href="/nyugrossman/">NYU Grossman School of Medicine</a>. Dr. Axelrad's own experience with Crohn’s disease drives his commitment to improving patient outcomes. Learn more about his work at ShermanPrize.org
Gastroenterology & Hepatology | NYU Langone Health (@nyulh_gastrohep) 's Twitter Profile Photo

In a late-breaking abstract at #ACG2024, Violeta Popov, MD PhD presented a systematic review and meta-analysis evaluating the impact of GLP-1RA on GI endoscopy and potential safety concerns linked to delayed gastric emptying.

In a late-breaking abstract at #ACG2024, <a href="/PopovVioleta/">Violeta Popov, MD PhD</a> presented a systematic review and meta-analysis evaluating the impact of GLP-1RA on GI endoscopy and potential safety concerns linked to delayed gastric emptying.
Gastroenterology & Hepatology | NYU Langone Health (@nyulh_gastrohep) 's Twitter Profile Photo

Countdown to #TLM2024! Don't miss Dr. Sam Sigal AASLD in San Diego, present on "Breaking Down Barriers to Hepatitis B Care: Community & Faith-Based Collaborations" on 11/17 @ the Inclusion & Diversity Committee Symposium: Tools to Improve Liver Health Equity #LiverTwitter

Countdown to #TLM2024! Don't miss Dr. Sam Sigal
<a href="/AASLDtweets/">AASLD</a> in San Diego, present on "Breaking Down Barriers to Hepatitis B Care: Community &amp; Faith-Based Collaborations" on 11/17 @ the Inclusion &amp; Diversity Committee Symposium: Tools to Improve Liver Health Equity #LiverTwitter
Mark B. Pochapin, MD (@markpochapin) 's Twitter Profile Photo

Congratulations to Jordan Axelrad, MD, MPH NYU Langone Health on receiving the Sherman Emerging Leader Prize at the 2024 AIBD conference. Your leadership, passion, excellence, scientific rigor, and compassion represent us at our best! Congratulations! #AIBD2024 #IBDConference

Congratulations  to   <a href="/DrJordanAxelrad/">Jordan Axelrad, MD, MPH</a> <a href="/nyulangone/">NYU Langone Health</a> on receiving the Sherman Emerging Leader Prize at the 2024 AIBD conference.  Your leadership, passion, excellence, scientific rigor, and compassion represent us at our best! 
Congratulations!  #AIBD2024 #IBDConference
Simon Hong (@simonhongmd) 's Twitter Profile Photo

All things JAK with Jordan Axelrad, MD, MPH at Gastroenterology & Hepatology | NYU Langone Health #BigGutSeminars #IBD ✅ UPA effective for CD perianal fistula ✅ Network metas provide indirect comparative data: UPA🥇effective for both UC/CD ✅ Of the side effects - most common may be acne (“JAKne”)☝️discuss w pt!

All things JAK with <a href="/DrJordanAxelrad/">Jordan Axelrad, MD, MPH</a> at <a href="/NYULH_GastroHep/">Gastroenterology & Hepatology | NYU Langone Health</a> #BigGutSeminars #IBD

✅ UPA effective for CD perianal fistula
✅ Network metas provide indirect comparative data: UPA🥇effective for both UC/CD
✅ Of the side effects - most common may be acne (“JAKne”)☝️discuss w pt!